spec sheet3 rows
Teoritin is a Russian antiallergic drug built on a methylxanthine scaffold, marketed as an H1 blocker with an additional anti-inflammatory action.
- Russian antiallergic built on a methylxanthine scaffold
- Shares the benzhydrylpiperazine fragment behind cetirizine and hydroxyzine
- H1 blockade predictable straight from the structure
- Marketed with an added action on inflammation
- A rare find outside the usual antihistamine shelf
Mechanism
The molecule is a xanthine carrying a benzhydrylpiperazine side chain, the same fragment that gives cetirizine and hydroxyzine their H1 affinity, so H1 blockade is expected on structure alone. The claimed anti-inflammatory component beyond H1 blockade rests on Russian publications from the group that developed it, and no independent replication exists in the international literature.
Safetyrisks and cautions, not medical advice
a Russia only medicine with no INN, no international approval and no independent evidence base outside the literature of the group that developed it
Subjective profileweighing the evidence above
The structure gives the game away usefully: a benzhydrylpiperazine hanging off a xanthine is the same fragment that makes cetirizine and hydroxyzine antihistamines, so H1 blockade is a safe bet from the drawing alone. What is not a safe bet is the extra anti-inflammatory action the marketing rests on, which exists only in papers from the group that developed the molecule, with no INN, no approval anywhere else and no independent replication. Modern antihistamines are cheap and thoroughly characterised, which leaves no gap here that needs filling.
Where to buy
Suppliers
Vendors carrying Teoritin, with live product details and codes. Links are affiliate links that support the wiki at no cost to you.
RUPharma🌐
Teoritin